TNF and chronic recurrent multifocal osteomyelitis: Just after turning 18, in summer of 2024, she had a relapse of CRMO, and experienced a CRMO relapse, prompting the adult rheumatologist to initiate treatment with a TNF-α inhibitor, Adalimumab.